| Schedule of computation of basic and diluted loss per share |
The
following tables set forth the computation of basic and diluted loss per share of Class A Ordinary Shares and Class B Ordinary Shares:
Schedule of computation of basic and diluted loss per share
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
For the Year Ended
December 31, 2025 | |
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
US$ | | |
US$ | |
| Basic and diluted loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Allocation of undistributed loss | |
$ | (9,587,938 | ) | |
$ | (1,958,552 | ) |
| Denominator | |
| | | |
| | |
| Number of shares used in per share computation | |
| 23,402,915 | | |
| 4,780,575 | |
| Basic and diluted loss per share | |
$ | (0.41 | ) | |
$ | (0.41 | ) |
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
For the Year Ended
December 31, 2024 | |
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
US$ | | |
US$ | |
| Basic and diluted loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Allocation of undistributed loss | |
$ | (4,845,217 | ) | |
$ | (1,038,934 | ) |
| Denominator | |
| | | |
| | |
| Number of shares used in per share computation | |
| 22,294,896 | | |
| 4,780,575 | |
| Basic and diluted loss per share | |
$ | (0.22 | ) | |
$ | (0.22 | ) |
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
For the Year Ended
December 31, 2023 | |
| | |
Class A
Ordinary Shares | | |
Class B
Ordinary Shares | |
| | |
US$ | | |
US$ | |
| Basic and diluted loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Allocation of undistributed loss | |
$ | (6,402,122 | ) | |
$ | (1,559,402 | ) |
| Denominator | |
| | | |
| | |
| Number of shares used in per share computation | |
| 19,626,646 | | |
| 4,780,575 | |
| Basic and diluted loss per share | |
$ | (0.33 | ) | |
$ | (0.33 | ) |
|
| Summary of anti-dilutive instruments |
The
summary of anti-dilutive instruments excluded from the computation of earnings per share, amount is as follows:
Summary of anti-dilutive instruments
| | |
Warrants | | |
Convertible Notes | | |
Total | |
| Common Stock subject to outstanding: | |
| | | |
| | | |
| | |
| For the year ended December 31, 2025 | |
| 4,949,156 | | |
| 841,072 | | |
| 5,790,228 | |
| For the year ended December 31, 2024 | |
| 4,943,608 | | |
| 1,206,141 | | |
| 6,149,749 | |
| For the year ended December 31, 2023 | |
| 5,570,275 | | |
| - | | |
| 5,570,275 | |
| Antidilutive securities excluded from computation of earnings per share, amount | |
| 5,570,275 | | |
| - | | |
| 5,570,275 | |
|